Tango Therapeutics

TNGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.916 B

$27.07 -6.65%

Close of 7 Aug 2026

Revenue

$62.4M

#2673 by revenue

Earnings

-$101.6M

Loss-making

Shares outstanding

142,688,851

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#66Genmab A/SGMAB$4.01B
#67Viking TherapeuticsVKTX$4.00B
#68Tango TherapeuticsTNGX$3.92B
#69Telix PharmaceuticalsTLX$3.90B
#70Legend BiotechLEGN$3.85B

Where these numbers come from

Share counts and financials for Tango Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.